FR5027M - - Google Patents

Info

Publication number
FR5027M
FR5027M FR47139A FR47139A FR5027M FR 5027 M FR5027 M FR 5027M FR 47139 A FR47139 A FR 47139A FR 47139 A FR47139 A FR 47139A FR 5027 M FR5027 M FR 5027M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR47139A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR47139A priority Critical patent/FR5027M/fr
Priority to LU51250A priority patent/LU51250A1/xx
Priority to BE682177A priority patent/BE682177A/xx
Priority to CH836466A priority patent/CH455813A/fr
Priority to GB2574466A priority patent/GB1073770A/en
Priority to NL6608079A priority patent/NL6608079A/xx
Application granted granted Critical
Publication of FR5027M publication Critical patent/FR5027M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR47139A 1965-06-11 1966-01-25 Expired FR5027M (pt)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR47139A FR5027M (pt) 1966-01-25 1966-01-25
LU51250A LU51250A1 (pt) 1965-06-11 1966-06-03
BE682177A BE682177A (pt) 1965-06-11 1966-06-07
CH836466A CH455813A (fr) 1965-06-11 1966-06-08 Procédé pour la préparation de nouveaux dérivés de la pyridazone
GB2574466A GB1073770A (en) 1965-06-11 1966-06-09 Pyridazone derivatives and process for their preparation
NL6608079A NL6608079A (pt) 1965-06-11 1966-06-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR47139A FR5027M (pt) 1966-01-25 1966-01-25

Publications (1)

Publication Number Publication Date
FR5027M true FR5027M (pt) 1967-04-24

Family

ID=8599673

Family Applications (1)

Application Number Title Priority Date Filing Date
FR47139A Expired FR5027M (pt) 1965-06-11 1966-01-25

Country Status (1)

Country Link
FR (1) FR5027M (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220735A3 (en) * 1985-10-30 1988-06-15 Richter Gedeon Vegyeszeti Gyar R.T. 3(2h)-pyridazinone derivatives, a process and intermediates for preparing them and medicaments containing them and/or other 3(2h)-pyridazinone derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0220735A3 (en) * 1985-10-30 1988-06-15 Richter Gedeon Vegyeszeti Gyar R.T. 3(2h)-pyridazinone derivatives, a process and intermediates for preparing them and medicaments containing them and/or other 3(2h)-pyridazinone derivatives

Similar Documents

Publication Publication Date Title
AU5917865A (pt)
FR5027M (pt)
AU433222B2 (pt)
AU414526B2 (pt)
AU218666A (pt)
AU612166A (pt)
AU6703465A (pt)
BE674882A (pt)
BE666282A (pt)
BE693724A (pt)
BE693612A (pt)
BE693509A (pt)
BE692901A (pt)
BE692812A (pt)
BE692668A (pt)
BE692226A (pt)
BE689044A (pt)
BE685303A (pt)
BE676332A (pt)
BE675139A (pt)
BE675084A (pt)
BE674987A (pt)
BE654686A (pt)
BE674792A (pt)
BE693989A (pt)